SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1179.0

(-0.08%)

Gross Profit Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual gross profit in 2023 was 329.57 Million INR , down -62.36% from previous year.
SMS Lifesciences India Limited's latest quarterly gross profit in 2024 Q1 was 148.37 Million INR , up 11.09% from previous quarter.
SMS Lifesciences India Limited reported a annual gross profit of 875.57 Million INR in annual gross profit 2022, up 0.02% from previous year.
SMS Lifesciences India Limited reported a annual gross profit of 875.42 Million INR in annual gross profit 2021, up 24.68% from previous year.
SMS Lifesciences India Limited reported a quarterly gross profit of 96.45 Million INR for 2023 Q3, down -59.91% from previous quarter.
SMS Lifesciences India Limited reported a quarterly gross profit of 240.6 Million INR for 2023 Q2, up 39.14% from previous quarter.

Annual Gross Profit Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Gross Profit of SMS Lifesciences India Limited (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	329.57 Million INR	-62.36%
2022	875.57 Million INR	0.02%
2021	875.42 Million INR	24.68%
2020	702.12 Million INR	20.13%
2019	584.47 Million INR	-12.5%
2018	667.99 Million INR	83.55%
2017	363.92 Million INR	-62.02%
2016	958.3 Million INR	0.0%
2015	- INR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	148.37 Million INR	11.09%
2023 Q3	96.45 Million INR	-59.91%
2023 Q2	240.6 Million INR	39.14%
2023 Q1	172.92 Million INR	-6.52%
2023 Q4	133.56 Million INR	38.47%
2023 FY	329.57 Million INR	-62.36%
2022 Q2	218.58 Million INR	-2.44%
2022 FY	875.57 Million INR	0.02%
2022 Q4	184.98 Million INR	-25.4%
2022 Q1	224.04 Million INR	14.59%
2022 Q3	247.96 Million INR	13.44%
2021 Q4	195.51 Million INR	-16.88%
2021 Q3	235.22 Million INR	-2.41%
2021 Q1	203.66 Million INR	20.03%
2021 FY	875.42 Million INR	24.68%
2021 Q2	241.02 Million INR	18.34%
2020 Q1	158.84 Million INR	65.02%
2020 FY	702.12 Million INR	20.13%
2020 Q4	169.67 Million INR	-3.1%
2020 Q3	175.1 Million INR	-11.79%
2020 Q2	198.51 Million INR	24.97%
2019 Q2	188.34 Million INR	6.54%
2019 FY	584.47 Million INR	-12.5%
2019 Q4	96.25 Million INR	-12.85%
2019 Q3	110.45 Million INR	-41.36%
2019 Q1	176.77 Million INR	7.55%
2018 Q3	199.37 Million INR	26.06%
2018 FY	667.99 Million INR	83.55%
2018 Q4	164.36 Million INR	-17.56%
2018 Q1	146.1 Million INR	50.19%
2018 Q2	158.15 Million INR	8.25%
2017 FY	363.92 Million INR	-62.02%
2017 Q4	97.27 Million INR	-57.51%
2017 Q1	246.08 Million INR	76.98%
2017 Q2	186.7 Million INR	-24.13%
2017 Q3	228.94 Million INR	22.62%
2016 Q1	277.04 Million INR	0.0%
2016 Q2	231.06 Million INR	-16.6%
2016 FY	958.3 Million INR	0.0%
2016 Q3	301.4 Million INR	30.44%
2016 Q4	139.04 Million INR	-53.87%
2015 FY	- INR	0.0%

Peer Gross Profit Comparison of SMS Lifesciences India Limited

Name	Gross Profit	Gross Profit Difference
Biocon Limited	91.73 Billion INR	99.641%
Blue Jet Healthcare Limited	3.15 Billion INR	89.568%
Concord Biotech Limited	7.56 Billion INR	95.643%
Dishman Carbogen Amcis Limited	4.9 Billion INR	93.279%
Jubilant Ingrevia Limited	9.16 Billion INR	96.404%
Lyka Labs Limited	145.95 Million INR	-125.811%
Panacea Biotec Limited	1.42 Billion INR	76.916%
Piramal Pharma Limited	24.47 Billion INR	98.653%
Supriya Lifescience Limited	2.65 Billion INR	87.572%
Syngene International Limited	12.43 Billion INR	97.35%
TAKE Solutions Limited	183.42 Million INR	-79.684%
Zota Health Care Limited	332.52 Million INR	0.887%